1. Home
  2. ACLS vs RCUS Comparison

ACLS vs RCUS Comparison

Compare ACLS & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$81.49

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.18

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
RCUS
Founded
1995
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
ACLS
RCUS
Price
$81.49
$23.18
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$98.80
$29.38
AVG Volume (30 Days)
505.2K
2.1M
Earning Date
02-09-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.25
N/A
Revenue
$853,135,000.00
$240,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.90
N/A
P/E Ratio
$19.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.40
$6.50
52 Week High
$102.93
$26.40

Technical Indicators

Market Signals
Indicator
ACLS
RCUS
Relative Strength Index (RSI) 43.80 53.76
Support Level $82.02 $21.80
Resistance Level $84.35 $23.49
Average True Range (ATR) 3.36 1.18
MACD -0.56 -0.25
Stochastic Oscillator 9.83 47.60

Price Performance

Historical Comparison
ACLS
RCUS

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: